Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 10751 [2018-04841]

Download as PDF Federal Register / Vol. 83, No. 48 / Monday, March 12, 2018 / Notices Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Hewlett Packard Enterprise Company, Palo Alto, CA; IQE, Inc., Bethlehem, PA; TTM Technologies, Inc., Costa Mesa, CA; National Technology and Engineering Solutions of Sandia, LLC, Albuquerque, NM; The Aerospace Corporation, El Segundo, CA; and University of Washington, Seattle, WA, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and AIM Photonics intends to file additional written notifications disclosing all changes in membership. On June 16, 2016, AIM Photonics filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 25, 2016 (81 FR 48450). The last notification was filed with the Department on October 25, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 16, 2017 (82 FR 53527). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2018–04839 Filed 3–9–18; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division amozie on DSK30RV082PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on January 18, 2018, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. VerDate Sep<11>2014 18:12 Mar 09, 2018 Jkt 244001 Specifically, Bramante Bioscience, Elmira Heights, NY; California Institute of Biomedical Research (Calibr), La Jolla, CA; CIYIS, LLC, Atlanta, GA; Combat Medical Systems, Harrisburg, NC; Cortical Metrics, LLC, Carrboro, NC; Duke University, Durham, NC; Friedman Research Corporation, Austin, TX; General Dynamics Information Technology, Inc., Fairfax, VA; Indiana Biosciences Research Institute, Indianapolis, IN; Iowa State University, Ames, IA; Ischemix, Inc., North Grafton, MA; Israel Innovation Authority, Airport City, ISRAEL; Michigan State University, East Lansing, MI; NeuroRx, Inc., Wilmington, DE; Prytime Medical Devices, Inc., Boerne, TX; Rutgers, The State University of New Jersey, New Brunswick, NJ; Sheltagen Medical Ltd, Atlit, ISRAEL; Studio Kinection, Inc. dba ‘‘Kinection’’, Napa, CA; TearSolutions, Inc., Charlottesville, VA; The Johns Hopkins University Applied Physics Laboratory, LLC, Laurel, MD; The Regents of the University of Michigan, Ann Arbor, MI; The University of Alabama at Birmingham, Birmingham, AL; The University of Texas at San Antonio, San Antonio, TX; The Washington University, St. Louis, MO; TheraNova, LLC, San Francisco, CA; Thought Leadership and Innovation Foundation (TLI Foundation), McLean, VA; Tympanogen, Inc., Williamsburg, VA; United Solutions, LLC, Rockville, MD; Virginia Polytechnic Institute and State University, Blacksburg, VA; William Marsh Rice University, Houston, TX; and Williams-Jones Consulting, Greenville, SC; have been added as parties to this venture. Also, CUBRC, Inc., Buffalo, NY; GeoVax, Inc., Smyrna, GA; KIYATEC, Inc., Greenville, SC; Manzanita Pharmaceuticals, Inc., Woodside, CA; Spherium Biomed SL, Barcelona, SPAIN, and Weinberg Medical Physics LLC, North Bethesda, MD; have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014, MTEC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on October 6, 2017. A notice was published in the Federal PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 10751 Register pursuant to Section 6(b) of the Act on November 6, 2017 (82 FR 51433). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2018–04841 Filed 3–9–18; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—DVD Copy Control Association Notice is hereby given that, on February 15, 2018, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), DVD Copy Control Association (‘‘DVD CCA’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, TEAC Corp., Tokyo, JAPAN, has been added as a party to this venture. Also, Tohei Industrial Co., Ltd., Fukushima-ken, JAPAN; Skypine Electronics (Shenzhen) Co., Ltd., Shenzhen City, PEOPLE’S REPUBLIC OF CHINA; PitsExpert Technology Co., Ltd., Taipei, TAIWAN; Jiangmen Simon Electronics Co., Ltd., Jiangmen, PEOPLE’S REPUBLIC OF CHINA; Cinram GmbH, Olyphant, PA; Societe Nouvelle Areacem (S.N.A.), Tourouvre, FRANCE; and Ziotech Corp., Chino, CA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and DVD CCA intends to file additional written notifications disclosing all changes in membership. On April 11, 2001, DVD CCA filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on August 3, 2001 (66 FR 40727). The last notification was filed with the Department on November 21, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the E:\FR\FM\12MRN1.SGM 12MRN1

Agencies

[Federal Register Volume 83, Number 48 (Monday, March 12, 2018)]
[Notices]
[Page 10751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04841]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 18, 2018, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Bramante Bioscience, Elmira Heights, NY; 
California Institute of Biomedical Research (Calibr), La Jolla, CA; 
CIYIS, LLC, Atlanta, GA; Combat Medical Systems, Harrisburg, NC; 
Cortical Metrics, LLC, Carrboro, NC; Duke University, Durham, NC; 
Friedman Research Corporation, Austin, TX; General Dynamics Information 
Technology, Inc., Fairfax, VA; Indiana Biosciences Research Institute, 
Indianapolis, IN; Iowa State University, Ames, IA; Ischemix, Inc., 
North Grafton, MA; Israel Innovation Authority, Airport City, ISRAEL; 
Michigan State University, East Lansing, MI; NeuroRx, Inc., Wilmington, 
DE; Prytime Medical Devices, Inc., Boerne, TX; Rutgers, The State 
University of New Jersey, New Brunswick, NJ; Sheltagen Medical Ltd, 
Atlit, ISRAEL; Studio Kinection, Inc. dba ``Kinection'', Napa, CA; 
TearSolutions, Inc., Charlottesville, VA; The Johns Hopkins University 
Applied Physics Laboratory, LLC, Laurel, MD; The Regents of the 
University of Michigan, Ann Arbor, MI; The University of Alabama at 
Birmingham, Birmingham, AL; The University of Texas at San Antonio, San 
Antonio, TX; The Washington University, St. Louis, MO; TheraNova, LLC, 
San Francisco, CA; Thought Leadership and Innovation Foundation (TLI 
Foundation), McLean, VA; Tympanogen, Inc., Williamsburg, VA; United 
Solutions, LLC, Rockville, MD; Virginia Polytechnic Institute and State 
University, Blacksburg, VA; William Marsh Rice University, Houston, TX; 
and Williams-Jones Consulting, Greenville, SC; have been added as 
parties to this venture.
    Also, CUBRC, Inc., Buffalo, NY; GeoVax, Inc., Smyrna, GA; KIYATEC, 
Inc., Greenville, SC; Manzanita Pharmaceuticals, Inc., Woodside, CA; 
Spherium Biomed SL, Barcelona, SPAIN, and Weinberg Medical Physics LLC, 
North Bethesda, MD; have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on October 6, 
2017. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 6, 2017 (82 FR 51433).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2018-04841 Filed 3-9-18; 8:45 am]
 BILLING CODE 4410-11-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.